BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  AstraZeneca CEO: COVID-19 Vaccine Could Still Be Ready by End of 2020

  Despite a temporary pause on its COVID-19 vaccine trial, AstraZeneca Chief Executive Officer Pascal Soriot said the preventative drug could still be available for commercial use by the end of the year, or in early 2021 barring any other setback.

  September 11, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Poll: Trust in Fauci and the CDC is Declining Ahead of the November Election

  Six months into a global pandemic and public trust is waning in its support for public health officials in charge of the nation’s response to the novel coronavirus, according to a new poll.

  September 11, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Vertex’s CF Blockbuster Trikafta Effective in Kids 6 to 11 Years of Age

  Based on the positive results of Trikafta, the company plans to submit sNDA to the FDA in the fourth quarter and other regulatory agencies around the world afterward.

  September 11, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  BioCapital

  Clinical Catch-Up: September 7-11

  It was a busy week for clinical trial updates. Here’s a look.

  September 11, 2020

   · 

  10 min read

   · 

  Mark Terry
• 

  Biotech Beach

  Untangling the Body’s Smart Sensors: What RNA Binding Proteins Can Tell Us About Gene Regulation

  Can you imagine organizing more than 10 terabytes of data into a useful network of information? But researchers are trying to do just that by finding RNA Binding Proteins.

  September 11, 2020

   · 

  7 min read

   · 

  Chelsea Weidman Burke
• 

  Policy

  Mental Health to Play a Role in the Defense Strategy for Elizabeth Holmes

  Elizabeth Holmes, the founder and former chief executive officer of failed diagnostics company Theranos, will be examined by a psychologist and psychiatrist ahead of her looming trial for fraud.

  September 11, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Biotech IPOs: Intra-Cellular Therapies, 10x Genomics and Spero Therapeutics

  It was a busy week for biopharma, biotech and medical device initial public offerings (IPOs). Here’s a look.

  September 11, 2020

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  MiNA Therapeutics Raises $30 Million, Looks to Propel Its Lead Candidate

  The financing will be used by MiNA to advance the company’s pipeline of proprietary, first-in-class, small activating RNA therapeutics.

  September 11, 2020

   · 

  3 min read

   · 

  Krystle Vermes
• 

  Business

  Investors Pump $30 Million into Orasis Pharmaceuticals’ Series C Financing Round

  Orasis Pharmaceuticals has closed on $30 million dollars in Series C financing that will propel its corrective eye drop candidate for presbyopia symptoms, CSF-1, through Phase III clinical trials.

  September 11, 2020

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Eli Lilly Reports Positive Results of Reyvow in Phase III Migraine Attack Study

  Eli Lilly and Company announced today that it has seen positive results from CENTURION, its Phase III study looking into Reyvow (lasmiditan) for migraine attacks.

  September 11, 2020

   · 

  3 min read

   · 

  Krystle Vermes